News
10h
Pharmaceutical Technology on MSNOrionis and Genentech link on oncology small-molecule glue medicinesThe partnership will include $105m upfront to Orionis, with the potential for further payments that could exceed $2bn.
Throughout its nearly 100-year manufacturing history, the crack resistance of natural rubber—one of the world's most widely used biomaterials—hasn't improved much. Until now. Materials researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results